

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.94627026 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.80888499 |
| 3 | response to peptidoglycan (GO:0032494) | 4.64108401 |
| 4 | respiratory burst (GO:0045730) | 4.60343760 |
| 5 | mast cell activation (GO:0045576) | 4.51262590 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 4.36581219 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24802614 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24802614 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.24802614 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24802614 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.24802614 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24802614 |
| 13 | myeloid cell activation involved in immune response (GO:0002275) | 4.23448289 |
| 14 | neutrophil activation (GO:0042119) | 4.21929898 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.17214823 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14927077 |
| 17 | detection of bacterium (GO:0016045) | 4.12161242 |
| 18 | granulocyte activation (GO:0036230) | 4.11823316 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 4.08531703 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.03686115 |
| 21 | leukocyte aggregation (GO:0070486) | 4.03181801 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02461725 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01809631 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.89359353 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.88467280 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79504688 |
| 27 | defense response to protozoan (GO:0042832) | 3.76729899 |
| 28 | detection of biotic stimulus (GO:0009595) | 3.74065789 |
| 29 | mast cell activation involved in immune response (GO:0002279) | 3.73538587 |
| 30 | mast cell degranulation (GO:0043303) | 3.73538587 |
| 31 | leukocyte degranulation (GO:0043299) | 3.72787953 |
| 32 | superoxide anion generation (GO:0042554) | 3.68175168 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.65395053 |
| 34 | response to protozoan (GO:0001562) | 3.61109448 |
| 35 | neutrophil mediated immunity (GO:0002446) | 3.57939931 |
| 36 | regulation of B cell differentiation (GO:0045577) | 3.56677268 |
| 37 | myeloid dendritic cell activation (GO:0001773) | 3.51618006 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.49754564 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.48347121 |
| 40 | negative regulation of interleukin-17 production (GO:0032700) | 3.45104012 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42152752 |
| 42 | megakaryocyte development (GO:0035855) | 3.34626354 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.33521715 |
| 44 | myeloid leukocyte activation (GO:0002274) | 3.32749078 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32736715 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31683543 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 3.31359690 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.29515148 |
| 49 | definitive hemopoiesis (GO:0060216) | 3.27851923 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27349601 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25047690 |
| 52 | mature B cell differentiation (GO:0002335) | 3.21702445 |
| 53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.20397545 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.20397545 |
| 55 | * regulation of mast cell activation (GO:0033003) | 3.19720227 |
| 56 | reactive oxygen species biosynthetic process (GO:1903409) | 3.18221290 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17753486 |
| 58 | regulation of tolerance induction (GO:0002643) | 3.17032589 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.16857440 |
| 60 | myeloid dendritic cell differentiation (GO:0043011) | 3.16000611 |
| 61 | negative regulation of cell killing (GO:0031342) | 3.13819837 |
| 62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13819837 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.13656653 |
| 64 | cellular extravasation (GO:0045123) | 3.11578076 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.10653491 |
| 66 | microglial cell activation (GO:0001774) | 3.10238612 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10168338 |
| 68 | lymphoid progenitor cell differentiation (GO:0002320) | 3.09009613 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 3.07866798 |
| 70 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.07089859 |
| 71 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06787067 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06787067 |
| 73 | positive thymic T cell selection (GO:0045059) | 3.05372100 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05070909 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03498431 |
| 76 | response to host immune response (GO:0052572) | 3.03498431 |
| 77 | activated T cell proliferation (GO:0050798) | 3.03337630 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02350113 |
| 79 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.02339465 |
| 80 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.01678826 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 3.01048068 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 3.00822654 |
| 83 | macrophage activation (GO:0042116) | 2.99911370 |
| 84 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99509894 |
| 85 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98326058 |
| 86 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97609693 |
| 87 | response to interferon-beta (GO:0035456) | 2.96012969 |
| 88 | neutrophil chemotaxis (GO:0030593) | 2.94530021 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94086454 |
| 90 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92948308 |
| 91 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92916624 |
| 92 | detection of other organism (GO:0098543) | 2.92674517 |
| 93 | B cell mediated immunity (GO:0019724) | 2.92649371 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.92064766 |
| 95 | regulation of interferon-alpha production (GO:0032647) | 2.91092482 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90788180 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89508144 |
| 98 | negative thymic T cell selection (GO:0045060) | 2.89203142 |
| 99 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87342653 |
| 100 | positive regulation of type 2 immune response (GO:0002830) | 2.87000258 |
| 101 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.86295906 |
| 102 | neutrophil migration (GO:1990266) | 2.85160468 |
| 103 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83853559 |
| 104 | T cell migration (GO:0072678) | 2.83397185 |
| 105 | myeloid leukocyte mediated immunity (GO:0002444) | 2.82637331 |
| 106 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81877457 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 2.80402038 |
| 108 | negative T cell selection (GO:0043383) | 2.80332366 |
| 109 | leukocyte mediated cytotoxicity (GO:0001909) | 2.78765277 |
| 110 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78708540 |
| 111 | regulation of interleukin-17 production (GO:0032660) | 2.78570414 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78535927 |
| 113 | regulation of regulated secretory pathway (GO:1903305) | 2.78306711 |
| 114 | granulocyte chemotaxis (GO:0071621) | 2.78045603 |
| 115 | phagocytosis, engulfment (GO:0006911) | 2.77369554 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76605363 |
| 117 | response to host (GO:0075136) | 2.76147590 |
| 118 | response to host defenses (GO:0052200) | 2.76147590 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76147590 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75983039 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.75974476 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.75872319 |
| 123 | positive regulation of macrophage differentiation (GO:0045651) | 2.74996379 |
| 124 | interferon-gamma production (GO:0032609) | 2.74948564 |
| 125 | germinal center formation (GO:0002467) | 2.74588600 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.74105847 |
| 127 | response to fungus (GO:0009620) | 2.72848318 |
| 128 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72734838 |
| 129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72500349 |
| 130 | response to interleukin-15 (GO:0070672) | 2.72332487 |
| 131 | regulation of macrophage cytokine production (GO:0010935) | 2.71783969 |
| 132 | cellular response to interferon-beta (GO:0035458) | 2.70782742 |
| 133 | B cell homeostasis (GO:0001782) | 2.70238231 |
| 134 | leukocyte cell-cell adhesion (GO:0007159) | 2.69792960 |
| 135 | cellular response to zinc ion (GO:0071294) | 2.69235407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.53221673 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37012245 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.55433093 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.52280217 |
| 5 | * BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.15253116 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.97330403 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.95196605 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.90505177 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.79907485 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76997469 |
| 11 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.63095589 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41092861 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.08514921 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.00200953 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95869440 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.86754022 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77036505 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57124244 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53711610 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49445896 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.45292383 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44326830 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.42731326 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26659691 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25574048 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.24992069 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.17117696 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15847864 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15490783 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14230625 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.12694144 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07357826 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04833081 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.04532580 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04438667 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85822546 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79956337 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78759907 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74781821 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74661925 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68198663 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66451280 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65725897 |
| 44 | * MYB_26560356_Chip-Seq_TH1_Human | 1.62866384 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62783850 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59902186 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59060519 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55342892 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.55114515 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54685840 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.52393218 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51418036 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50846439 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44164086 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38801251 |
| 56 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38547649 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38201294 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34553207 |
| 59 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33556638 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32426760 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30381306 |
| 62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29456935 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28840191 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27846688 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27107358 |
| 66 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26366858 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26103366 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25172136 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22468374 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22337988 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19272409 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17865214 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17748738 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16751592 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15070725 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14579646 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13433949 |
| 78 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12960629 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12251952 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09574651 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08884581 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08352243 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07672579 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.06996137 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06942160 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06421142 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06150526 |
| 88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01378698 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98409679 |
| 90 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98067994 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96452765 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93932238 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91582961 |
| 94 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.91567069 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87445738 |
| 96 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85363696 |
| 97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.84221335 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82998353 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82236857 |
| 100 | * MAF_26560356_Chip-Seq_TH2_Human | 0.80206482 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76124274 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75464732 |
| 103 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74509036 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72879014 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69535402 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68923327 |
| 107 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68661645 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68143301 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68005230 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.65875217 |
| 111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.65474769 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65353351 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.63176771 |
| 114 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.63060866 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.62872149 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.61180947 |
| 117 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.61174442 |
| 118 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58710353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.30449810 |
| 2 | MP0003436_decreased_susceptibility_to | 3.37193506 |
| 3 | MP0009785_altered_susceptibility_to | 3.36103131 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.29204000 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.28953309 |
| 6 | MP0003724_increased_susceptibility_to | 3.08664989 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.07337414 |
| 8 | MP0005671_abnormal_response_to | 3.03858932 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.97405451 |
| 10 | MP0005025_abnormal_response_to | 2.92758265 |
| 11 | MP0003303_peritoneal_inflammation | 2.76027826 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.66651835 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.66448659 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.59995210 |
| 15 | MP0002723_abnormal_immune_serum | 2.55225813 |
| 16 | MP0006082_CNS_inflammation | 2.51160979 |
| 17 | MP0001800_abnormal_humoral_immune | 2.48742275 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.46943190 |
| 19 | * MP0001819_abnormal_immune_cell | 2.45836770 |
| 20 | MP0000685_abnormal_immune_system | 2.33543931 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.22537392 |
| 22 | MP0001790_abnormal_immune_system | 2.21700577 |
| 23 | MP0005387_immune_system_phenotype | 2.21700577 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 2.05474071 |
| 25 | MP0001545_abnormal_hematopoietic_system | 2.05474071 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 2.02690983 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.99893838 |
| 28 | MP0002398_abnormal_bone_marrow | 1.96219447 |
| 29 | MP0005451_abnormal_body_composition | 1.95830475 |
| 30 | MP0002405_respiratory_system_inflammati | 1.88742798 |
| 31 | MP0009278_abnormal_bone_marrow | 1.86705398 |
| 32 | * MP0000716_abnormal_immune_system | 1.85937594 |
| 33 | MP0001853_heart_inflammation | 1.82430615 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.79825160 |
| 35 | MP0004510_myositis | 1.79321593 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.78667619 |
| 37 | MP0003075_altered_response_to | 1.73243567 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.72129470 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.71081301 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.67317647 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.66514634 |
| 42 | MP0002006_tumorigenesis | 1.66169670 |
| 43 | MP0000343_altered_response_to | 1.65385462 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.64717756 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.62041756 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.59788699 |
| 47 | MP0005310_abnormal_salivary_gland | 1.55477434 |
| 48 | * MP0002429_abnormal_blood_cell | 1.55377814 |
| 49 | MP0002722_abnormal_immune_system | 1.52928284 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.49017497 |
| 51 | MP0001851_eye_inflammation | 1.42833880 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.39671775 |
| 53 | MP0005409_darkened_coat_color | 1.38833840 |
| 54 | MP0008469_abnormal_protein_level | 1.37992279 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.33887370 |
| 56 | MP0009840_abnormal_foam_cell | 1.33551748 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.30823867 |
| 58 | MP0000858_altered_metastatic_potential | 1.29879514 |
| 59 | MP0004947_skin_inflammation | 1.27793353 |
| 60 | MP0003448_altered_tumor_morphology | 1.27745195 |
| 61 | MP0003866_abnormal_defecation | 1.22964396 |
| 62 | MP0001873_stomach_inflammation | 1.21832040 |
| 63 | MP0005166_decreased_susceptibility_to | 1.21563619 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.20442271 |
| 65 | MP0009764_decreased_sensitivity_to | 1.20088059 |
| 66 | * MP0000920_abnormal_myelination | 1.18086658 |
| 67 | MP0003828_pulmonary_edema | 1.15755519 |
| 68 | MP0000490_abnormal_crypts_of | 1.14746183 |
| 69 | MP0008004_abnormal_stomach_pH | 1.10939765 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.05198617 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.04326006 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.00587098 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.99640559 |
| 74 | * MP0002998_abnormal_bone_remodeling | 0.99013899 |
| 75 | MP0002933_joint_inflammation | 0.98877753 |
| 76 | MP0004381_abnormal_hair_follicle | 0.95908015 |
| 77 | MP0003690_abnormal_glial_cell | 0.95716459 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.91254616 |
| 79 | MP0004147_increased_porphyrin_level | 0.89362784 |
| 80 | MP0008260_abnormal_autophagy | 0.87445619 |
| 81 | MP0001188_hyperpigmentation | 0.86821143 |
| 82 | MP0008057_abnormal_DNA_replication | 0.85420855 |
| 83 | MP0003091_abnormal_cell_migration | 0.81924877 |
| 84 | MP0001663_abnormal_digestive_system | 0.81014886 |
| 85 | MP0005390_skeleton_phenotype | 0.79120744 |
| 86 | MP0003045_fibrosis | 0.78665188 |
| 87 | MP0005164_abnormal_response_to | 0.77791672 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.77754195 |
| 89 | MP0009763_increased_sensitivity_to | 0.75944205 |
| 90 | MP0002009_preneoplasia | 0.70416720 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.70277186 |
| 92 | MP0000249_abnormal_blood_vessel | 0.68359981 |
| 93 | MP0006054_spinal_hemorrhage | 0.67765407 |
| 94 | MP0003329_amyloid_beta_deposits | 0.66132582 |
| 95 | MP0000371_diluted_coat_color | 0.65716440 |
| 96 | MP0003300_gastrointestinal_ulcer | 0.64348328 |
| 97 | MP0008873_increased_physiological_sensi | 0.62942345 |
| 98 | MP0000604_amyloidosis | 0.62053890 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.59863917 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.58374028 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.58012781 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.57204372 |
| 103 | MP0009115_abnormal_fat_cell | 0.56846581 |
| 104 | MP0002075_abnormal_coat/hair_pigmentati | 0.54749176 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.53898771 |
| 106 | MP0004883_abnormal_blood_vessel | 0.53796656 |
| 107 | MP0004484_altered_response_of | 0.52809146 |
| 108 | * MP0003795_abnormal_bone_structure | 0.52555679 |
| 109 | MP0002133_abnormal_respiratory_system | 0.50434469 |
| 110 | MP0002132_abnormal_respiratory_system | 0.49500053 |
| 111 | MP0003633_abnormal_nervous_system | 0.49491053 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.48522941 |
| 113 | MP0001905_abnormal_dopamine_level | 0.47841271 |
| 114 | MP0003186_abnormal_redox_activity | 0.47636365 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.45640368 |
| 116 | MP0008874_decreased_physiological_sensi | 0.43553202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.39881442 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.70015224 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.24306023 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.97654077 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.66552020 |
| 6 | Myositis (HP:0100614) | 4.49237423 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.45269798 |
| 8 | Recurrent skin infections (HP:0001581) | 4.44483013 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.29223351 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.20518473 |
| 11 | Obstructive lung disease (HP:0006536) | 4.20518473 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.08811225 |
| 13 | Stomatitis (HP:0010280) | 3.88637294 |
| 14 | Petechiae (HP:0000967) | 3.85820986 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.69485945 |
| 16 | Optic neuritis (HP:0100653) | 3.59364969 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.59364969 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.55714745 |
| 19 | Cellulitis (HP:0100658) | 3.51713913 |
| 20 | Gingivitis (HP:0000230) | 3.50363960 |
| 21 | Meningitis (HP:0001287) | 3.46416883 |
| 22 | Orchitis (HP:0100796) | 3.45954446 |
| 23 | Recurrent viral infections (HP:0004429) | 3.43919589 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.43557206 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42540998 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42540998 |
| 27 | Chronic otitis media (HP:0000389) | 3.32946044 |
| 28 | T lymphocytopenia (HP:0005403) | 3.32943118 |
| 29 | Amyloidosis (HP:0011034) | 3.30010133 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.22000806 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.19842694 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.15148024 |
| 33 | Thrombocytosis (HP:0001894) | 3.13746477 |
| 34 | IgM deficiency (HP:0002850) | 3.02881206 |
| 35 | Disinhibition (HP:0000734) | 2.95864266 |
| 36 | Vasculitis (HP:0002633) | 2.88101374 |
| 37 | Periodontitis (HP:0000704) | 2.84108929 |
| 38 | Epistaxis (HP:0000421) | 2.83449762 |
| 39 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.76093335 |
| 40 | Agnosia (HP:0010524) | 2.72946457 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71447822 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.69213553 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.69207669 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.67896476 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59212501 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59212501 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59212501 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.57221028 |
| 49 | Prostate neoplasm (HP:0100787) | 2.55426505 |
| 50 | Osteomyelitis (HP:0002754) | 2.54832338 |
| 51 | Leukocytosis (HP:0001974) | 2.53969953 |
| 52 | Recurrent pneumonia (HP:0006532) | 2.53486542 |
| 53 | Urticaria (HP:0001025) | 2.50690779 |
| 54 | Pulmonary embolism (HP:0002204) | 2.49156779 |
| 55 | Axonal loss (HP:0003447) | 2.48563946 |
| 56 | Abnormal platelet function (HP:0011869) | 2.45932074 |
| 57 | Impaired platelet aggregation (HP:0003540) | 2.45932074 |
| 58 | Gangrene (HP:0100758) | 2.44529775 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.43116305 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.42634849 |
| 61 | Episodic fever (HP:0001954) | 2.42550359 |
| 62 | Purpura (HP:0000979) | 2.38320262 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.37903901 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.36771131 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.34509829 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.34361823 |
| 67 | Hematochezia (HP:0002573) | 2.33744391 |
| 68 | Thyroiditis (HP:0100646) | 2.33735657 |
| 69 | Gingival bleeding (HP:0000225) | 2.31757456 |
| 70 | Hemoptysis (HP:0002105) | 2.31689153 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.30150834 |
| 72 | Basal ganglia calcification (HP:0002135) | 2.29197481 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.28420526 |
| 74 | Myocardial infarction (HP:0001658) | 2.28126012 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.28124947 |
| 76 | Encephalitis (HP:0002383) | 2.26115792 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22011571 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.21077738 |
| 79 | Anorexia (HP:0002039) | 2.20723954 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.18262232 |
| 81 | Aplastic anemia (HP:0001915) | 2.17888875 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.16354303 |
| 83 | Colitis (HP:0002583) | 2.14465043 |
| 84 | Albinism (HP:0001022) | 2.14330491 |
| 85 | Keratoconjunctivitis (HP:0001096) | 2.13639852 |
| 86 | Arterial thrombosis (HP:0004420) | 2.13009082 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.11297244 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11259496 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11259496 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11259496 |
| 91 | Lymphopenia (HP:0001888) | 2.10560035 |
| 92 | Sepsis (HP:0100806) | 2.09409101 |
| 93 | Inappropriate behavior (HP:0000719) | 2.09267561 |
| 94 | Vertigo (HP:0002321) | 2.09260514 |
| 95 | Hepatosplenomegaly (HP:0001433) | 2.08807745 |
| 96 | Polyneuropathy (HP:0001271) | 2.07837269 |
| 97 | Pustule (HP:0200039) | 2.06223254 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.04059877 |
| 99 | Increased IgM level (HP:0003496) | 2.03327430 |
| 100 | Abnormality of the endocardium (HP:0004306) | 2.02609529 |
| 101 | Glomerulopathy (HP:0100820) | 2.00944844 |
| 102 | Abnormality of T cells (HP:0002843) | 2.00881671 |
| 103 | Increased serum ferritin (HP:0003281) | 2.00397209 |
| 104 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99045526 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.98960990 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98960990 |
| 107 | Abnormality of eosinophils (HP:0001879) | 1.97995854 |
| 108 | Viral hepatitis (HP:0006562) | 1.97656505 |
| 109 | Increased CSF protein (HP:0002922) | 1.97366036 |
| 110 | Patchy hypopigmentation of hair (HP:0011365) | 1.96709322 |
| 111 | Slow saccadic eye movements (HP:0000514) | 1.96390841 |
| 112 | Granulocytopenia (HP:0001913) | 1.93457738 |
| 113 | Mutism (HP:0002300) | 1.92996536 |
| 114 | Papilledema (HP:0001085) | 1.92918430 |
| 115 | Eosinophilia (HP:0001880) | 1.92522521 |
| 116 | Dysostosis multiplex (HP:0000943) | 1.91716346 |
| 117 | White forelock (HP:0002211) | 1.90662195 |
| 118 | Cheilitis (HP:0100825) | 1.88429983 |
| 119 | Peritonitis (HP:0002586) | 1.87932950 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87910722 |
| 121 | Amaurosis fugax (HP:0100576) | 1.87689185 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.87684881 |
| 123 | Increased IgE level (HP:0003212) | 1.86030382 |
| 124 | Menorrhagia (HP:0000132) | 1.84144000 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.82193762 |
| 126 | Glomerulonephritis (HP:0000099) | 1.80745368 |
| 127 | Recurrent bronchitis (HP:0002837) | 1.79201862 |
| 128 | Loss of speech (HP:0002371) | 1.76996160 |
| 129 | Skin ulcer (HP:0200042) | 1.75558557 |
| 130 | Chest pain (HP:0100749) | 1.73791458 |
| 131 | Arthralgia (HP:0002829) | 1.70952818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.67122407 |
| 2 | IRAK4 | 3.67551160 |
| 3 | KIT | 3.53147415 |
| 4 | BLK | 3.26327111 |
| 5 | MAP4K1 | 2.91834558 |
| 6 | TXK | 2.82932339 |
| 7 | FES | 2.70407680 |
| 8 | MAP3K14 | 2.62644566 |
| 9 | MAP3K12 | 2.46583742 |
| 10 | PRPF4B | 2.42917008 |
| 11 | TNIK | 2.36694897 |
| 12 | TEC | 2.32512856 |
| 13 | TBK1 | 2.31911850 |
| 14 | BTK | 2.20944158 |
| 15 | IKBKE | 1.94206578 |
| 16 | ERN1 | 1.91827451 |
| 17 | MATK | 1.91156554 |
| 18 | CSF1R | 1.87582016 |
| 19 | SYK | 1.86392433 |
| 20 | TAOK3 | 1.83220194 |
| 21 | IKBKB | 1.72918355 |
| 22 | MAPKAPK5 | 1.68738645 |
| 23 | MAP3K3 | 1.63993350 |
| 24 | PBK | 1.61373781 |
| 25 | IRAK3 | 1.59284024 |
| 26 | LYN | 1.54436917 |
| 27 | TGFBR2 | 1.53495309 |
| 28 | JAK3 | 1.53455977 |
| 29 | GRK7 | 1.50957178 |
| 30 | CLK1 | 1.46042421 |
| 31 | TYK2 | 1.43722850 |
| 32 | LCK | 1.41543304 |
| 33 | PIM2 | 1.39559693 |
| 34 | HCK | 1.39222309 |
| 35 | EPHB1 | 1.37567625 |
| 36 | MAP3K13 | 1.31216432 |
| 37 | ZAP70 | 1.28923438 |
| 38 | ADRBK2 | 1.24951886 |
| 39 | MUSK | 1.22867572 |
| 40 | MAP3K1 | 1.22638435 |
| 41 | PIK3CG | 1.21672376 |
| 42 | YES1 | 1.13563423 |
| 43 | CSK | 1.10169380 |
| 44 | MAP2K3 | 1.04444197 |
| 45 | NME2 | 1.01577745 |
| 46 | PIM1 | 0.96556574 |
| 47 | TRPM7 | 0.95674581 |
| 48 | KSR2 | 0.93783064 |
| 49 | JAK1 | 0.89933322 |
| 50 | ITK | 0.88405482 |
| 51 | SIK2 | 0.85775733 |
| 52 | TAOK2 | 0.85643793 |
| 53 | CDC42BPA | 0.83642370 |
| 54 | STK16 | 0.82745046 |
| 55 | SIK3 | 0.81264162 |
| 56 | MAPK7 | 0.80012072 |
| 57 | STK10 | 0.78493365 |
| 58 | MAP3K2 | 0.77611370 |
| 59 | CDK19 | 0.77554654 |
| 60 | CAMKK2 | 0.75719784 |
| 61 | MARK2 | 0.75661585 |
| 62 | NLK | 0.73667413 |
| 63 | MST4 | 0.72091491 |
| 64 | TNK2 | 0.72077846 |
| 65 | MOS | 0.69145861 |
| 66 | MAP3K6 | 0.66785446 |
| 67 | STK4 | 0.66369879 |
| 68 | TGFBR1 | 0.66104870 |
| 69 | BMPR2 | 0.65526586 |
| 70 | CHUK | 0.65172613 |
| 71 | SGK3 | 0.64265355 |
| 72 | FGR | 0.64190642 |
| 73 | MARK3 | 0.63175169 |
| 74 | PDK1 | 0.60575160 |
| 75 | MKNK1 | 0.59946982 |
| 76 | MAPK4 | 0.59554652 |
| 77 | ABL2 | 0.58205051 |
| 78 | PRKCD | 0.58132954 |
| 79 | EPHA3 | 0.56973942 |
| 80 | PTK2B | 0.56791698 |
| 81 | FGFR3 | 0.56661958 |
| 82 | SGK2 | 0.56239022 |
| 83 | NEK9 | 0.55463289 |
| 84 | EIF2AK2 | 0.54518185 |
| 85 | JAK2 | 0.54176888 |
| 86 | DAPK2 | 0.53876186 |
| 87 | MAP3K5 | 0.53745157 |
| 88 | CAMK1D | 0.52442643 |
| 89 | HIPK2 | 0.50646593 |
| 90 | RPS6KL1 | 0.48581013 |
| 91 | RPS6KC1 | 0.48581013 |
| 92 | ACVR1B | 0.48438615 |
| 93 | TTN | 0.46955599 |
| 94 | GRK6 | 0.46935252 |
| 95 | IRAK1 | 0.46664187 |
| 96 | CDK6 | 0.46422210 |
| 97 | RPS6KA4 | 0.46267263 |
| 98 | MAP2K6 | 0.45980327 |
| 99 | ABL1 | 0.45880769 |
| 100 | MAPK12 | 0.45780974 |
| 101 | VRK1 | 0.45672940 |
| 102 | PDK2 | 0.45126993 |
| 103 | DAPK1 | 0.43762265 |
| 104 | CDK8 | 0.43349160 |
| 105 | PRKCQ | 0.43311300 |
| 106 | FLT3 | 0.43286074 |
| 107 | BMPR1B | 0.43050831 |
| 108 | EIF2AK3 | 0.41448681 |
| 109 | MST1R | 0.40576179 |
| 110 | PDPK1 | 0.40223581 |
| 111 | FYN | 0.39954510 |
| 112 | CAMK1 | 0.39354039 |
| 113 | RPS6KA6 | 0.39076037 |
| 114 | PDGFRB | 0.38306241 |
| 115 | NEK6 | 0.38137276 |
| 116 | MAP3K11 | 0.36068533 |
| 117 | KSR1 | 0.35715977 |
| 118 | CAMKK1 | 0.35411763 |
| 119 | TESK2 | 0.35091206 |
| 120 | IRAK2 | 0.35000067 |
| 121 | MAPKAPK2 | 0.34967132 |
| 122 | PRKD2 | 0.34481435 |
| 123 | PTK6 | 0.34472705 |
| 124 | CAMK4 | 0.33303012 |
| 125 | STK11 | 0.33155331 |
| 126 | RAF1 | 0.32456067 |
| 127 | MAP3K7 | 0.31931249 |
| 128 | LRRK2 | 0.29649935 |
| 129 | MAP2K7 | 0.28950909 |
| 130 | EEF2K | 0.28767960 |
| 131 | BRSK2 | 0.28694361 |
| 132 | RPS6KA5 | 0.28307504 |
| 133 | TAOK1 | 0.26500844 |
| 134 | PRKG2 | 0.26236792 |
| 135 | TIE1 | 0.26080551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16594585 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45572507 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24191332 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22973176 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20946421 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.07988521 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06988116 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02179229 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01815191 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01315199 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00620499 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99360440 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.98692333 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91040117 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.90528537 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88600134 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.85897541 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.85549888 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77985254 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77674478 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.72073620 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70160266 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.68697195 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.62545915 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.61069078 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.57697954 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53402084 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49754560 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40279131 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.38811726 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.37435944 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.35633144 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35627570 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34652077 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34248778 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.33470457 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26075887 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25788671 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25204629 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24623945 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.23834434 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23828197 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23308328 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22959401 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16185829 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15840358 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.08158011 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.04130622 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03384066 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00408215 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95457123 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91796530 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91718951 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90749127 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 0.90107251 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89614755 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89005016 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87392741 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84150227 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80630631 |
| 61 | DNA replication_Homo sapiens_hsa03030 | 0.77214381 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76910550 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75988657 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70741064 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69654749 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.65482524 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64679671 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60981231 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60218327 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57857905 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57392051 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57175681 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55510741 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.55302831 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.54461772 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53417681 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.52541477 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52531614 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51720247 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50863936 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50091995 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49550455 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48780252 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47876141 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47395317 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47135894 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45488296 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.43044596 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42831320 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42366926 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39515719 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37987320 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37927705 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37506526 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36371965 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35024580 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35013281 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34987662 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34676100 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.34519144 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34244678 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33846279 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33253994 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31670162 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.31214610 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30847859 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29373861 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26789299 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25507632 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25457924 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25014244 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24170676 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23941506 |
| 114 | Mismatch repair_Homo sapiens_hsa03430 | 0.23101952 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22719636 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22202624 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22132809 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19863961 |

